目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.1.1. Segment Definitions
1.2. Regional Scope
1.3. Estimates and Forecast Timeline
1.4. Objective
1.4.1. Objective 1
1.4.2. Objective2
1.4.3. Objective 3
1.5. Research Methodology
1.6. Information Procurement
1.6.1. Purchased Database
1.6.2. GVR’s Internal Database
1.6.3. Secondary Sources
1.6.4. Primary Research
1.7. Information or Data Analysis:
1.7.1. Data Analysis Models
1.8. Market Formulation & Validation
1.9. Model Details
1.9.1. Commodity Flow Analysis
1.10. List of Secondary Sources
1.11. List of Abbreviations

Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables and Trends
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Expanding use of miRNA in drug development & therapeutics
3.2.1.2. Increasing cancer prevalence and need for early-stage diagnostics
3.2.2. Market Restraint Analysis
3.2.2.1. High cost associated with microRNA kits and other products
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis

Chapter 4. Product & Service Business Analysis
4.1. Segment Dashboard
4.2. MicroRNA Market: Product & Service Movement Analysis
4.3. Product
4.3.1. Product Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2. Instruments
4.3.2.1. Instruments Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2.2. By Technology
4.3.2.2.1. Real-Time PCR
4.3.2.2.1.1. Real-Time PCR Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2.2.2. Microarray
4.3.2.2.2.1. Microarray Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2.2.3. NGS
4.3.2.2.3.1. NGS Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2.2.4. Others
4.3.2.2.4.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2.3. By Workflow
4.3.2.3.1. Isolation & Purification
4.3.2.3.1.1. Isolation & Purification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2.3.2. miRNA cDNA Synthesis
4.3.2.3.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2.3.3. Profiling, Localization, & Qualification
4.3.2.3.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2.3.4. Functional Analysis & Others
4.3.2.3.4.1. Functional Analysis & Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.2.3.5. Others
4.3.2.3.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3. Consumables
4.3.3.1. Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3.2. By Specimen
4.3.3.2.1. Whole Blood
4.3.3.2.1.1. Whole Blood Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3.2.2. Serum
4.3.3.2.2.1. Serum Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3.2.3. Plasma
4.3.3.2.3.1. Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3.2.4. FFPE
4.3.3.2.4.1. FFPE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3.2.5. Fresh Frozen Tissue
4.3.3.2.5.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3.2.6. Others
4.3.3.2.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3.3. By Workflow
4.3.3.3.1. Isolation & Purification
4.3.3.3.1.1. Isolation & Purification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3.3.2. miRNA cDNA Synthesis
4.3.3.3.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3.3.3. Profiling, Localization, & Qualification
4.3.3.3.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3.3.4. Functional Analysis & Others
4.3.3.3.4.1. Functional Analysis & Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.3.3.3.5. Others
4.3.3.3.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4. Services
4.4.1. Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2. By Service Type
4.4.2.1. Isolation & Purification
4.4.2.1.1. Isolation & Purification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2.2. miRNA cDNA Synthesis
4.4.2.2.1. miRNA cDNA Synthesis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2.3. Profiling, Localization, & Qualification
4.4.2.3.1. Profiling, Localization, & Qualification Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2.4. Functional Analysis
4.4.2.4.1. Functional Analysis Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.2.5. Others
4.4.2.5.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3. By Specimen
4.4.3.1. Whole Blood
4.4.3.1.1. Whole Blood Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3.2. Serum
4.4.3.2.1. Serum Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3.3. Plasma
4.4.3.3.1. Plasma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3.4. FFPE
4.4.3.4.1. FFPE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3.5. Fresh Frozen Tissue
4.4.3.5.1. Fresh Frozen Tissue Market Estimates and Forecasts, 2021 - 2033 (USD Million)
4.4.3.6. Others
4.4.3.6.1. Others Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Application Business Analysis
5.1. Segment Dashboard
5.2. MicroRNA Market: Application Movement Analysis
5.3. Cancer
5.3.1. Cancer Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.4. Infectious Diseases
5.4.1. Infectious Diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.5. Immunological Disorder
5.5.1. Immunological Disorder Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.6. Cardiovascular Disease
5.6.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.7. Neurological Disease
5.7.1. Neurological Disease Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
5.8. Others
5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. End Use Business Analysis
6.1. Segment Dashboard
6.2. MicroRNA Market: End Use Movement Analysis
6.3. Biotechnology & Pharmaceutical Companies
6.3.1. Biotechnology & Pharmaceutical Companies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.4. Academic & Government Research Institutes
6.4.1. Academic & Government Research Institutes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
6.5. Other End-users
6.5.1. Other End-users Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Regional Business Analysis
7.1. MicroRNA Market Share By Region, 2024 & 2033
7.2. North America
7.2.1. North America MicroRNA Market, 2021 - 2033 (USD Million)
7.2.2. U.S.
7.2.2.1. Key Country Dynamics
7.2.2.2. Regulatory framework
7.2.2.3. Competitive Scenario
7.2.2.4. U.S. MicroRNA Market, 2021 - 2033 (USD Million)
7.2.3. Canada
7.2.3.1. Key Country Dynamics
7.2.3.2. Regulatory framework
7.2.3.3. Competitive Scenario
7.2.3.4. Canada MicroRNA Market, 2021 - 2033 (USD Million)
7.2.4. Mexico
7.2.4.1. Key Country Dynamics
7.2.4.2. Regulatory framework
7.2.4.3. Competitive Scenario
7.2.4.4. Mexico MicroRNA Market, 2021 - 2033 (USD Million)
7.3. Europe
7.3.1. Europe MicroRNA Market, 2021 - 2033 (USD Million)
7.3.2. UK
7.3.2.1. Key Country Dynamics
7.3.2.2. Regulatory framework
7.3.2.3. Competitive Scenario
7.3.2.4. UK MicroRNA Market, 2021 - 2033 (USD Million)
7.3.3. Germany
7.3.3.1. Key Country Dynamics
7.3.3.2. Regulatory framework
7.3.3.3. Competitive Scenario
7.3.3.4. Germany MicroRNA Market, 2021 - 2033 (USD Million)
7.3.4. France
7.3.4.1. Key Country Dynamics
7.3.4.2. Regulatory framework
7.3.4.3. Competitive Scenario
7.3.4.4. France MicroRNA Market, 2021 - 2033 (USD Million)
7.3.5. Italy
7.3.5.1. Key Country Dynamics
7.3.5.2. Regulatory framework
7.3.5.3. Competitive Scenario
7.3.5.4. Italy MicroRNA Market, 2021 - 2033 (USD Million)
7.3.6. Spain
7.3.6.1. Key Country Dynamics
7.3.6.2. Regulatory framework
7.3.6.3. Competitive Scenario
7.3.6.4. Spain MicroRNA Market, 2021 - 2033 (USD Million)
7.3.7. Denmark
7.3.7.1. Key Country Dynamics
7.3.7.2. Regulatory framework
7.3.7.3. Competitive Scenario
7.3.7.4. Denmark MicroRNA Market, 2021 - 2033 (USD Million)
7.3.8. Sweden
7.3.8.1. Key Country Dynamics
7.3.8.2. Regulatory framework
7.3.8.3. Competitive Scenario
7.3.8.4. Sweden MicroRNA Market, 2021 - 2033 (USD Million)
7.3.9. Norway
7.3.9.1. Key Country Dynamics
7.3.9.2. Regulatory framework
7.3.9.3. Competitive Scenario
7.3.9.4. Norway MicroRNA Market, 2021 - 2033 (USD Million)
7.4. Asia Pacific
7.4.1. Asia Pacific MicroRNA Market, 2021 - 2033 (USD Million)
7.4.2. Japan
7.4.2.1. Key Country Dynamics
7.4.2.2. Regulatory framework
7.4.2.3. Competitive Scenario
7.4.2.4. Japan MicroRNA Market, 2021 - 2033 (USD Million)
7.4.3. China
7.4.3.1. Key Country Dynamics
7.4.3.2. Regulatory framework
7.4.3.3. Competitive Scenario
7.4.3.4. China MicroRNA Market, 2021 - 2033 (USD Million)
7.4.4. India
7.4.4.1. Key Country Dynamics
7.4.4.2. Regulatory framework
7.4.4.3. Competitive Scenario
7.4.4.4. India MicroRNA Market, 2021 - 2033 (USD Million)
7.4.5. Australia
7.4.5.1. Key Country Dynamics
7.4.5.2. Regulatory framework
7.4.5.3. Competitive Scenario
7.4.5.4. Australia MicroRNA Market, 2021 - 2033 (USD Million)
7.4.6. Thailand
7.4.6.1. Key Country Dynamics
7.4.6.2. Regulatory framework
7.4.6.3. Competitive Scenario
7.4.6.4. Thailand MicroRNA Market, 2021 - 2033 (USD Million)
7.4.7. South Korea
7.4.7.1. Key Country Dynamics
7.4.7.2. Regulatory framework
7.4.7.3. Competitive Scenario
7.4.7.4. South Korea MicroRNA Market, 2021 - 2033 (USD Million)
7.5. Latin America
7.5.1. Latin America MicroRNA Market, 2021 - 2033 (USD Million)
7.5.2. Brazil
7.5.2.1. Key Country Dynamics
7.5.2.2. Regulatory framework
7.5.2.3. Competitive Scenario
7.5.2.4. Brazil MicroRNA Market, 2021 - 2033 (USD Million)
7.5.3. Argentina
7.5.3.1. Key Country Dynamics
7.5.3.2. Regulatory framework
7.5.3.3. Competitive Scenario
7.5.3.4. Argentina MicroRNA Market, 2021 - 2033 (USD Million)
7.6. MEA
7.6.1. MEA MicroRNA Market, 2021 - 2033 (USD Million)
7.6.2. South Africa
7.6.2.1. Key Country Dynamics
7.6.2.2. Regulatory framework
7.6.2.3. Competitive Scenario
7.6.2.4. South Africa MicroRNA Market, 2021 - 2033 (USD Million)
7.6.3. Saudi Arabia
7.6.3.1. Key Country Dynamics
7.6.3.2. Regulatory framework
7.6.3.3. Competitive Scenario
7.6.3.4. Saudi Arabia MicroRNA Market, 2021 - 2033 (USD Million)
7.6.4. UAE
7.6.4.1. Key Country Dynamics
7.6.4.2. Regulatory framework
7.6.4.3. Competitive Scenario
7.6.4.4. UAE MicroRNA Market, 2021 - 2033 (USD Million)
7.6.5. Kuwait
7.6.5.1. Key Country Dynamics
7.6.5.2. Regulatory framework
7.6.5.3. Competitive Scenario
7.6.5.4. Kuwait MicroRNA Market, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape
8.1. Company Categorization
8.2. Strategy Mapping
8.3. Company Market Position Analysis, 2024
8.4. Company Profiles/Listing
8.4.1. Thermo Fisher Scientific
8.4.1.1. Overview
8.4.1.2. Financial Performance
8.4.1.3. Product Benchmarking
8.4.1.4. Strategic Initiatives
8.4.2. QIAGEN
8.4.2.1. Overview
8.4.2.2. Financial Performance
8.4.2.3. Product Benchmarking
8.4.2.4. Strategic Initiatives
8.4.3. Horizon Discovery Group plc.
8.4.3.1. Overview
8.4.3.2. Financial Performance
8.4.3.3. Product Benchmarking
8.4.3.4. Strategic Initiatives
8.4.4. Merck KGaA
8.4.4.1. Overview
8.4.4.2. Financial Performance
8.4.4.3. Product Benchmarking
8.4.4.4. Strategic Initiatives
8.4.5. Takara Bio, Inc.
8.4.5.1. Overview
8.4.5.2. Financial Performance
8.4.5.3. Product Benchmarking
8.4.5.4. Strategic Initiatives
8.4.6. LGC Limited
8.4.6.1. Overview
8.4.6.2. Financial Performance
8.4.6.3. Product Benchmarking
8.4.6.4. Strategic Initiatives
8.4.7. BioGenex
8.4.7.1. Overview
8.4.7.2. Financial Performance
8.4.7.3. Product Benchmarking
8.4.7.4. Strategic Initiatives
8.4.8. GeneCopoeia, Inc.
8.4.8.1. Overview
8.4.8.2. Financial Performance
8.4.8.3. Product Benchmarking
8.4.8.4. Strategic Initiatives
8.4.9. New England Biolabs
8.4.9.1. Overview
8.4.9.2. Financial Performance
8.4.9.3. Product Benchmarking
8.4.9.4. Strategic Initiatives
8.4.10. NanoString Technologies, Inc.
8.4.10.1. Overview
8.4.10.2. Financial Performance
8.4.10.3. Product Benchmarking
8.4.10.4. Strategic Initiatives
List of Tables
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Global MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 4 Global MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 5 Global MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 6 Global MicroRNA Market, by Region, 2021 - 2033 (USD Million)
Table 7 North America MicroRNA Market, by Country, 2021 - 2033 (USD Million)
Table 8 North America MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 9 North America MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 10 North America MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 11 U.S. MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 12 U.S. MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 13 U.S. MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 14 Canada MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 15 Canada MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 16 Canada MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 17 Mexico MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 18 Mexico MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 19 Mexico MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 20 Europe MicroRNA Market, by Country, 2021 - 2033 (USD Million)
Table 21 Europe MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 22 Europe MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 23 Europe MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 24 Germany MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 25 Germany MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 26 Germany MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 27 UK MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 28 UK MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 29 UK MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 30 France MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 31 France MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 32 France MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 33 Italy MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 34 Italy MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 35 Italy MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 36 Spain MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 37 Spain MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 38 Spain MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 39 Denmark MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 40 Denmark MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 41 Denmark MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 42 Norway MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 43 Norway MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 44 Norway MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 45 Sweden MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 46 Sweden MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 47 Sweden MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 48 Asia Pacific MicroRNA Market, by Country, 2021 - 2033 (USD Million)
Table 49 Asia Pacific MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 50 Asia Pacific MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 51 Asia Pacific MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 52 Asia Pacific MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 53 China MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 54 China MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 55 China MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 56 Japan MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 57 Japan MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 58 Japan MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 59 India MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 60 India MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 61 India MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 62 South Korea MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 63 South Korea MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 64 South Korea MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 65 Australia MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 66 Australia MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 67 Australia MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 68 Thailand MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 69 Thailand MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 70 Thailand MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 71 Latin America MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 72 Latin America MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 73 Latin America MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 74 Brazil MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 75 Brazil MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 76 Brazil MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 77 Argentina MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 78 Argentina MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 79 Argentina MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 80 Middle East & Africa MicroRNA Market, by Country, 2021 - 2033 (USD Million)
Table 81 Middle East & Africa MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 82 Middle East & Africa MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 83 Middle East & Africa MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 84 South Africa MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 85 South Africa MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 86 South Africa MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 87 Saudi Arabia MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 88 Saudi Arabia MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 89 Saudi Arabia MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 90 UAE MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 91 UAE MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 92 UAE MicroRNA Market, End-user, 2021 - 2033 (USD Million)
Table 93 Kuwait MicroRNA Market, by Product & Services, 2021 - 2033 (USD Million)
Table 94 Kuwait MicroRNA Market, by Application, 2021 - 2033 (USD Million)
Table 95 Kuwait MicroRNA Market, End-user, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 MicroRNA market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research process
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modelling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market outlook
Fig. 13 Segment snapshot
Fig. 14 Competitive landscape snapshot
Fig. 15 Market trends & outlook
Fig. 16 PESTEL analysis
Fig. 17 Porter’s five forces analysis
Fig. 18 MicroRNA market: Product & services outlook & key takeaways
Fig. 19 MicroRNA market: Product & services movement analysis
Fig. 20 Products Market, 2021 - 2033 (USD million)
Fig. 21 MicroRNA market: by product type
Fig. 22 Instruments Market, 2021 - 2033 (USD million)
Fig. 23 MicroRNA market: by technology
Fig. 24 Real Time PCR Market, 2021 - 2033 (USD million)
Fig. 25 Microarray Market, 2021 - 2033 (USD million)
Fig. 26 NGS Market, 2021 - 2033 (USD million)
Fig. 27 Others Market, 2021 - 2033 (USD million)
Fig. 28 MicroRNA market: by workflow
Fig. 29 Isolation & Purification Market, 2021 - 2033 (USD million)
Fig. 30 miRNA cDNA Synthesis Market, 2021 - 2033 (USD million)
Fig. 31 Profiling, Localization, & Quantification Market, 2021 - 2033 (USD million)
Fig. 32 Functional Analysis & Others Market, 2021 - 2033 (USD million)
Fig. 33 Others Market, 2021 - 2033 (USD million)
Fig. 34 Consumables Market, 2021 - 2033 (USD million)
Fig. 35 MicroRNA market: by specimen
Fig. 36 Whole Blood Market, 2021 - 2033 (USD million)
Fig. 37 Serum Market, 2021 - 2033 (USD million)
Fig. 38 Plasma Market, 2021 - 2033 (USD million)
Fig. 39 FFPE Market, 2021 - 2033 (USD million)
Fig. 40 Fresh Frozen Tissue Market, 2021 - 2033 (USD million)
Fig. 41 Others Market, 2021 - 2033 (USD million)
Fig. 42 MicroRNA market: by workflow
Fig. 43 Isolation & Purification Market, 2021 - 2033 (USD million)
Fig. 44 miRNA cDNA Synthesis Market, 2021 - 2033 (USD million)
Fig. 45 Profiling, Localization, & Quantification Market, 2021 - 2033 (USD million)
Fig. 46 Functional Analysis Market, 2021 - 2033 (USD million)
Fig. 47 Others Market, 2021 - 2033 (USD million)
Fig. 48 Services Market, 2021 - 2033 (USD million)
Fig. 49 MicroRNA market: by services type
Fig. 50 Isolation & Purification Market, 2021 - 2033 (USD million)
Fig. 51 miRNA cDNA Synthesis Market, 2021 - 2033 (USD million)
Fig. 52 Profiling, Localization, & Quantification Market, 2021 - 2033 (USD million)
Fig. 53 Functional Analysis Market, 2021 - 2033 (USD million)
Fig. 54 Others Market, 2021 - 2033 (USD million)
Fig. 55 MicroRNA market: specimen
Fig. 56 Whole Blood Market, 2021 - 2033 (USD million)
Fig. 57 Serum Market, 2021 - 2033 (USD million)
Fig. 58 Plasma Market, 2021 - 2033 (USD million)
Fig. 59 FFPE Market, 2021 - 2033 (USD million)
Fig. 60 Fresh Frozen Tissue Market, 2021 - 2033 (USD million)
Fig. 61 Others Market, 2021 - 2033 (USD million)
Fig. 62 MicroRNA market: Application outlook key takeaways
Fig. 63 MicroRNA market: Application movement analysis
Fig. 64 Cancer Market, 2021 - 2033 (USD million)
Fig. 65 Infectious Diseases Market, 2021 - 2033 (USD million)
Fig. 66 Immunological Disorder Market, 2021 - 2033 (USD million)
Fig. 67 Cardiovascular Disease Market, 2021 - 2033 (USD million)
Fig. 68 Neurological Disease Market, 2021 - 2033 (USD million)
Fig. 69 Others Market, 2021 - 2033 (USD million)
Fig. 70 MicroRNA market: End use outlook key takeaways
Fig. 71 MicroRNA market: End use movement analysis
Fig. 72 Biotechnology & Pharmaceutical Companies Market, 2021 - 2033 (USD million)
Fig. 73 Academic & Government Research Institutes Market, 2021 - 2033 (USD million)
Fig. 74 Others Market, 2021 - 2033 (USD million)
Fig. 75 Regional outlook
Fig. 76 Regional marketplace: Key takeaways
Fig. 77 North America microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 78 Key country dynamics
Fig. 79 U S microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 80 Key country dynamics
Fig. 81 Canada microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 82 Key country dynamics
Fig. 83 Mexico microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 84 Europe microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 85 Key country dynamics
Fig. 86 Germany microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 87 Key country dynamics
Fig. 88 UK microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 89 Key country dynamics
Fig. 90 France microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 91 Key country dynamics
Fig. 92 Italy microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 93 Key country dynamics
Fig. 94 Spain microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 95 Key country dynamics
Fig. 96 Denmark microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 97 Key country dynamics
Fig. 98 Sweden microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 99 Key country dynamics
Fig. 100 Norway microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 101 Asia Pacific microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 102 Key country dynamics
Fig. 103 Japan microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 104 Key country dynamics
Fig. 105 China microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 106 Key country dynamics
Fig. 107 India microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 108 Key country dynamics
Fig. 109 Australia microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 110 Key country dynamics
Fig. 111 Thailand microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 112 Key country dynamics
Fig. 113 South Korea microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 114 Latin America microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 115 Key country dynamics
Fig. 116 Brazil microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 117 Key country dynamics
Fig. 118 Argentina microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 119 MEA microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 120 Key country dynamics
Fig. 121 South Africa microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 122 Key country dynamics
Fig. 123 Saudi Arabia microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 124 Key country dynamics
Fig. 125 UAE microRNA market estimates and forecasts, 2021 - 2033 (USD million)
Fig. 126 Key country dynamics
Fig. 127 Kuwait microRNA market estimates and forecasts, 2021 - 2033 (USD million)